Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation

Hosted by FDA Office of Women's Health

Date: October 27, 2022

Time: 9 to 10 a.m. PST

Click here to register

Join the FDA Office of Women’s Health in collaboration with CDER’s Division of Pediatrics and Maternal Health for Part 2 of our discussion of the FDA Pregnancy and Lactation Labeling Final Rule, implemented in 2015. Although the current labeling system improved the presentation of information in prescription medication labeling, it highlighted the gaps in human data for medications used during pregnancy and lactation. The speakers will provide an overview of the studies enrolling pregnant and lactating individuals, the work FDA is doing to advance research in pregnant and lactating individuals, and information on how providers can become involved in advancing research in pregnant and lactating individuals. The webinar is open to the public and CME/CNE/CPE is available.

Questions? Please email FDAWebinar3@fda.hhs.gov

Comments are closed.